Back to All Transactions

For more information regarding this transaction contact:
  • Mike Townley Investment Banking 213.536.0241
  • Rob Martin Investment Banking 612.260.5850

VolitionRX Limited

Lake Street Capital Markets is pleased to announce it served as exclusive U.S. placement agent to VolitionRX Limited (OTC:VNRX), a blood-based cancer diagnostics company, in its private placement of 1,500,000 shares of common stock at $2.00 per share.  Gross proceeds totaled $3 million.

About VolitionRX

Located in Singapore and Belgium, VolitionRX is a life sciences company focused on developing diagnostic tests for cancer and other conditions.  The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present.

VolitionsRX’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests.  VolitionRX’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.


Mike Townley
Head of Investment Banking


Email Mike

Dave McDonald
Head of Life Science Investment Banking


Email Dave


Tim Klein

Investment Banking


Email Tim


Rob Martin

Investment Banking


Email Rob


Steve Rickman

Investment Banking


Email Steve